| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K49290616 | CTRPv2 | pan-cancer | AAC | -0.16 | 0.04 |
| mRNA | MLN4924 | CTRPv2 | pan-cancer | AAC | 0.069 | 0.05 |
| mRNA | PI-103 | CTRPv2 | pan-cancer | AAC | -0.07 | 0.05 |
| mRNA | CP724714 | GDSC1000 | pan-cancer | AAC | -0.067 | 0.05 |
| mRNA | pluripotin | CTRPv2 | pan-cancer | AAC | 0.07 | 0.05 |
| mRNA | LBW242 | CCLE | pan-cancer | AAC | 0.092 | 0.05 |
| mRNA | tanespimycin:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.074 | 0.05 |
| mRNA | HLI 373 | CTRPv2 | pan-cancer | AAC | -0.07 | 0.05 |
| mRNA | Crizotinib | GDSC1000 | pan-cancer | AAC | -0.11 | 0.05 |
| mRNA | PD-0325901 | gCSI | pan-cancer | AAC | 0.098 | 0.05 |